Connect with us
TOPEKA, Kan. — A new report from Georgetown University‘s Center for Children and Families highlights the critical role Medicaid plays in rural Kansas, where a significant...
BETHESDA, Md. — A sudden hiring freeze and suspension of public communications, meetings, and training workshops at the National Institutes of Health (NIH) have created chaos...
LOS ANGELES, Calif. – Former ‘Biggest Loser’ trainer Jillian Michaels has raised concerns about the widespread use of GLP-1 drugs like Ozempic for weight loss, urging...
PARIS, Jan 27 (Reuters) – The United States has reported its first outbreak of the H5N9 bird flu strain in poultry at a duck farm in...
SOUTH SAN FRANCISCO, Calif. — Akero Therapeutics, Inc. (NASDAQ: AKRO) announced groundbreaking results from its Phase 2b SYMMETRY study, revealing that its drug candidate efruxifermin (EFX)...
WASHINGTON, D.C. — President Donald Trump rescinded former President Joe Biden’s executive order aimed at lowering prescription drug costs for Americans on Monday, signaling a potential...
MINNEAPOLIS, Minn. — The University of Minnesota and Essentia Health announced a $1 billion plan on Friday to create a new nonprofit health system aimed at...
NATICK, Mass. — Allurion Technologies, Inc. (NYSE: ALUR) announced plans Tuesday to launch a clinical study combining its Allurion Program with GLP-1 agonists to address a...
WASHINGTON, D.C. — Cardio exercise is widely recognized as essential for health, but finding the motivation to start—or restart—can be a challenge. A new illustrated guide...
ST. LOUIS, Mo. — A groundbreaking study has uncovered both significant health benefits and potential risks associated with Ozempic and similar GLP-1 drugs, widely used for...